Despite the US Court of Appeals for the Federal Circuit's ruling in Amgen v Sandoz, significant uncertainty concerning two key provisions of the BCPIA remains, as Pharmaceutical Practice Group Co-Chairs Steve Coyle and Leslie-Anne Maxwell describe in their article, "Amgen v Sandoz: The Biosimilars Saga Continues" published in Life Sciences IP Review, Autumn 2015 issue.

Steve Coyle, Leslie-Anne Maxwell, and Chad Dever wrote the article, "Ogres and Trolls," for Life Sciences IP Review magazine about inter-partes review and post-grant review and life sciences patents. 

Anne Maxwell, Partner and Chair of the Pharmaceutical Patent Practice Group, reports on the Amgen Inc. v. Sanofi case that has cemented enablement requirements drawn from the Wands Test and three recent biotech decisions in her article, "Federal Circuit cases provide enablement guidance following Supreme Court decision," appearing in the July/August 2023 issue of the Patent Lawyer Magazine. 

Cantor Colburn Co-Managing Partners Michael Cantor and Philmore Colburn and Partners Todd Garabedian, Anne Maxwell, David Fox, Leah Reimer, and Karl Vick are 2023 Patent Stars, from Managing Intellectual Property.

AUTM’s Annual Meeting is on February 19-21, 2023, in Austin. Cantor Colburn's team at the meeting is Anne Maxwell, Bryan Zerhusen, Samantha Page, Charlie O'Brien and Nicholas Herrel. 

Cantor Colburn is proud to announce that seven partners have been recognized as 2022 IP STARS by Managing IP: Michael Cantor, Phil Colburn, David Fox, Todd Garabedian, Ph.D., Anne Maxwell, Ph.D., Leah Reimer, Ph.D. and Karl Vick.

Cantor Colburn’s Women’s Initiative hosted the Hartford Area AIPLA Women in IP Global Networking Event on April 7, 2022 at Parkville Market in Hartford.

Cantor Colburn partner Grant M. Ehrlich, Ph.D. has been elected the 72nd president of the Connecticut Intellectual Property Law Association (CIPLA). Joining him on the executive committee as the 2017-2018 program chair is fellow partner Leslie-Anne Maxwell, Ph.D. 

Anne Maxwell, Andrew Ryan, Steve Coyle, Christopher Potts, and Derek Denhart co-wrote the article "Will Biosimilar Applicants Opt Out of Patent Dance? Federal Court Ruling to Have Impact on Future Litigation Strategies," published by the Connecticut Law Tribune on April 20, 2015.

Members of Cantor Colburn's Pharmaceutical IP Services Practice Group co-authored an article on biosimilars entitled "BPCIA: How Long Does The Party Last And Do I Have To Dance?" that appeared in Law360 on March 24, 2015.  Leslie-Anne Maxwell, Andrew Ryan, Christopher Potts and Derek Denhart wrote the article which discusses Amgen Inc. v. Sandoz Inc.

Cantor Colburn Partner Anne Maxwell co-authored the article "Purple Book Launches New Chapter in Generic Drugs" that was published in the October 23, 2014 Connecticut Law Tribune.

Leslie-Anne Maxwell, Ph.D., Partner and Pharmaceutical Group Co-Chair, wrote "Diagnostic Method Patents in Doubt" for the April 27, 2014 Connecticut Law Tribune regarding recent guidance from the U.S. Patent and Trademark Office in view of the U.S. Supreme Court decisions in Assoc. for Molecular Pathology v. Myriad Genetics and Mayo Collaborative Services v. Prometheus Laboratories, Inc. 

Cantor Colburn is sponsoring the 13th Annual Pharma IPR Conference in Mumbai, India, on March 5-7, 2024. Steve Coyle, Anne Maxwell, and Nick Geiger of the Pharmaceutical Practice will attend and Steve will present, Improperly Listed Orange Book Patents – Recent FTC Scrutiny and Strategies for ANDA Filers to Take Advantage. The Pharma IPR conference is India's largest global pharm IP conference, and Cantor Colburn has sponsored and attended for many years. 

Dr. Leslie-Anne Maxwell, Partner and Chair of Pharmaceutical Patent Practice Group at Cantor Colburn LLP will be the guest of the American Chemical Society, New Haven and Connecticut Valley Sections, presenting, "When Intellectual Property is Your Only Property – Strategies for New Companies," on February 27, 2024. Dennis Jakiela, Ph.D., Patent Agent with Cantor Colburn, chairs the 2024 ACS–New Haven Executive Board, and Cantor Colburn is a sponsor.

BioCT's 10th Annual Holiday Party is on December 11 in New Haven. BioCT supports the needs and serves as the unified voice of the bioscience community in our state.

The 2023 Northeast Regional Meeting of the American Chemical Society (NERM 2023) will be organized by NESACS and will be hosted at Northeastern University in Boston. An all-star panel from Cantor Colburn LLP will discuss patent protection for innovative products or processes, which excludes others from making and selling the same products or using the same processes, can be critical to the profitability of tech companies. Cantor Colburn is proud to sponsor this meeting. 

The BIO International Convention 2023 is in Boston, June 5-8, 2023. Thousands of biotechnology and pharma leaders will come together for intensive networking to discover new opportunities and partnerships. Cantor Colburn partners Anne Maxwell, Ph.D. and Todd Garabedian, Ph.D. will attend. 

The Connecticut Intellectual Property Law Association (CIPLA) is hosting a discussion of Jack Daniel’s Properties, Inc. v. VIP Products LLC, led by Susan Kohlmann, Partner at Jenner & Block on April 17, 2023 at the Elm City Club in New Haven, Connecticut.

AUTM’s Annual Meeting is the largest gathering of technology transfer professionals. This annual, international meeting is a chance to connect, and gain insights from world-class speakers and panels from more than 90 educational sessions. The 2023 meeting will be held on February 19-22, 2023 in Austin, Texas.

Anne Maxwell, Ph.D., Esq., Partner and Chair of the firm's Pharmaceutical Patent Practice, will attend the Women Leaders in Life Sciences Law Conference in Boston on July 27-28, 2022.

UConn Law celebrate its past, present, and future at its Centennial Gala on June 11, 2022 in Hartford. The Gala is a culmination of centennial celebration events, at which the important work alumni have done thought the state, country and world will be recognized.

Leslie-Anne Maxwell, Ph.D., Esq. will attend The Yale Innovation Summit, on May 17-18, 2022 in New Haven, Connecticut. Anne is a Partner and chairs the firm's Pharmaceutical Patent Practice.

Cantor Colburn is pleased to host the AIPLA's Women in IP Law Virtual Global Networking event on April 7, 2022. The event, Power Happy Hour: Finding Balance, Building Community, will feature a short discussion around the important issue for women of feeling empowered and engaging in community. 

Anne Maxwell, Ph.D., Esq., Chair of Cantor Colburn's Pharmaceutical Patent Services Practice, will speak on at the Hatch-Waxman and BPCIA Passport to Proficiency Series, a virtual three-week program designed to provide new lawyers and executives for the life sciences industry with a solid foundation for understanding the essentials as well as the intricacies of Hatch-Waxman and BPCIA litigation and regulation. Dr. Maxwell speak on The Purple Book, focusing on generic pharmaceuticals. 

Cantor Colburn is pleased to sponsor the 9th Annual Pharma IPR Conference in Mumbai, India, on March 4-6, 2020. Steve Coyle and Anne Maxwell, Ph.D., Esq., co-chairs of the Pharmaceutical IP Services Practice Group, will attend, as will Nick Geiger.

Leslie-Anne Maxwell, Partner and Chair of Cantor Colburn's Pharmaceutical Patent Practice will attend the 2019 New England Venture Summit on December 4th, 2019 in Boston.

BioCT is holding its annual Bioscience & Beer Mixer on September 19, 2019 in Branford, Connecticut. Many members of Cantor Colburn's Life Sciences Practice Group will attend.  Cantor Colburn is a long-standing BioCT sponsor.

Anne Maxwell, Ph.D., Esq. will attend the Women Leaders in Life Sciences Law conference in Boston on July 25-26, 2019. 

The BIO International Convention 2019 is in Philadelphia on June 3-6, 2019. More than 16,000 biotechnology and pharma leaders will come together for intensive networking to discover new opportunities and  partnerships among a wide spectrum of life science and application areas, including drug discovery, biomanufacturing, genomics, biofuels, nanotechnology and cell therapy.  

Cantor Colburn is pleased to sponsor the 8th Annual Pharma IPR Conference in Mumbai, India, on March 6-8. 2019. Steve Coyle, who leads the Pharmaceutical IP Services Practice Group and co-chairs the Litigation Department, will speak on "ANDA Filing and Litigation: Procedures to Respond."

Pharmaceutical Practice Group Co-Chair and partner Anne Maxwell, Ph.D. will attend the Managing IP Life Sciences Forum on September 12, 2018 in New York City. The conference brings together industry leaders, inhouse and outside counsel, and members of the judiciary to discuss the latest decisions and significant changes affecting the life sciences industry today. 

The 2018 BIO International Convention will take place on June 4-7, 2018, in Boston, Massachusetts. Cantor Colburn attorneys Todd Garabedian, Ph.D. and Anne Maxwell, Ph.D. will attend the 25th annual event. More than 16,500 life sciences professionals will flock to Boston for the convention.

Cantor Colburn is pleased to sponsor the 7th Annual Pharma IPR Conference in Mumbai, India, on March 7-9. 2018. Cantor Colburn's Pharmaceutical IP Services Practice Group handles litigation, patent prosecution, inter partes reviews and other Patent Office review proceedings, opinions, landscapes, competitive intelligence, transactional services, portfolio management, biosimilar and interchangeable biological drugs, and more. Steve Coyle, who leads the Pharmaceutical Litigation Group, will speak on "ANDA filling and litigation: strategies to respond."

The Connecticut Intellectual Property Law Association (CIPLA) presents the workshop, “How IP Motivates Investors and Helps Price Drugs” on Wednesday, January 31, 2018 at the Graduate Club in New Haven, which includes a pre-event workshop for investors, entrepreneurs and attorneys.

The Summit on IP Due Diligence: Comprehensive and Practical Tips for Pharmaceutical, Biotechnology, and Medical Device Professionals will take place on November 2-3, 2017, in Philadelphia, Pennsylvania.

Cantor Colburn is proud to sponsor The 4th Annual Forum on Healthcare Innovation presented by The Jackson Laboratory for Genomic Medicine on October 25-26. 2017, at the Jackson Laboratory's Farmington, Connecticut headquarters. The Forum will focus on emerging science and technology that will change the future of healthcare, and innovations in healthcare.

Cantor Colburn is pleased to sponsor the Connecticut Intellectual Property Law Association's Judge's Dinner on May 11, 2017.

Stem Conn is Connecticut’s largest scientific conference, with 500 participants from academia, industry, and government. The 2017 event took place on April 27 at the Omni in New Haven.

Cantor Colburn is pleased to sponsor a CURE BioHaven event, "The Biopharmaceutical Industry’s Challenges in Drug Pricing" with Dr. John LaMattina, about drug pricing transparency.   

Cantor Colburn is a member of CURE, Connecticut’s bioscience network. Dr. John LaMattina is currently a Senior Partner at PureTech Health, and is the former Senior Vice President of Pfizer Inc. and former President of Pfizer Global Research and Development.

Cantor Colburn litigation partner Steve Coyle moderated the panel "The Ongoing Jurisdiction Debate: From Mylan to TC Heartland" at the Paragraph IV Disputes Conference in New York City, which the firm also sponsored.  Cantor Colburn has a dedicated Pharmaceutical Practice Group comprised of experienced litigators, Ph.D. chemists, and patent attorneys.

Leslie-Anne Maxwell, Ph.D., Partner and Co-Chair of the Pharmaceutical IP Services Practice, spoke on "Pharma Patent Battles" at the Pharma and IP Legal Summit in Morristown, New Jersey on December 7th.

The 2016 Forum on Healthcare Innovation was presented by The Jackson Laboratory in collaboration with the Connecticut Health Council. The Forum focused on two specific topics: coverage decisions for biomedical innovation  and emerging science and technology that will change the future of healthcare.

Anne Maxwell, Ph.D. and Todd Garabedian, Ph.D. are attending the BIO International Convention (BIO) in San Francisco, June 6-9, 2016.

Cantor Colburn is proud to sponsor the Innovation Summit, presented by the Connecticut Technology Council.  

Partner Leslie-Anne Maxwell will present a session at the American Conference Institute's 6th Annual Summit on Biosimilars, a forum on the legal, regulatory, patent, and commercial realities of follow-on biologics, June 1-3, 2015, in New York City.  Maxwell, who holds a PhD in chemistry from Yale University as well as a legal degree, co-chairs the firm's Pharmaceutical Practice Group.

Cantor Colburn is proud to be a returning sponsor of the UConn Health White Coat Gala.

Cantor Colburn partners Anne Maxwell, Ph.D., Esq. and Christopher Boehm, Esq. will present "Understanding and Valuing Intellectual Property" to the Connecticut Chapter of the National Association of Certified Valuation Analysts on Thursday, October 23rd at the New Haven Realtors Association in North Haven, Connecticut.  

Cantor Colburn partner Anne Maxwell, Ph.D. will speak on Patent Invalidity Due to the On Sale Bar - Hamilton Beach Brands, Inc. v. Sunbeam Products, Inc. during the 30th annual Joint Patent Practice Continuing Legal Education on April 23, 2014 in New York, New York. 

The Keynote Speaker will be Hon. Alan D. Lourie of the U.S. Court of Appeals, Federal Circuit. Key government officials from the USPTO and FTC have been invited to join the program to discuss the latest developments in IP law. These include Drew Hirshfeld, USPTO Deputy Commissioner for Patent Examination Policy; Markus Meier, FTC Assistant Director; Janet Gongola, USPTO Patent Reform Coordinator and Associate Commissioner for Patent Examination Policy; Nathan Kelley, USPTO Solicitor and Deputy General Counsel for IP; and Hon. Thomas  Giannetti, USPTO Lead Administrative Patent Judge, Patent & Trial Board. 

Cantor Colburn partner Anne Maxwell, Ph.D., joins a panel discussion of the Association for Molecular Pathology v. Myriad Genetics decision and its impact on entrepreneurship In diagnostics and customized medicines at the Yale School of Medicine in New Haven on Tuesday, March 25, from 4-6 PM. This BioHaven seminar has convened a panel of experts from various sectors of the biotech and pharmaceutical industry to discuss the business implications of cases such as Myriad.

Cantor Colburn is sponsoring two intellectual property (IP) symposia in Mumbai and Ahmedabad, India on Strategies for Managing Pharma, Biotech & Chemical Patent Portfolios attended by research and development scientists and IP professionals from India, presented by the Institute of Intellectual Property Research & Development. Co-Managing Partner Michael Cantor and Pharmaceutical Litigation Practice Group Chair Steve Coyle will lead a team to make presentations on strategic generic pharmaceutical patent portfolio issues.

Cantor Colburn is sponsoring two intellectual property (IP) symposia in Mumbai and Ahmedabad, India on Strategies for Managing Pharma, Biotech & Chemical Patent Portfolios attended by research and development scientists and IP professionals from India, presented by the Institute of Intellectual Property Research & Development. Co-Managing Partner Michael Cantor and Pharmaceutical Litigation Practice Group Chair Steve Coyle will lead a team to make presentations on strategic generic pharmaceutical patent portfolio issues.

Cantor Colburn is a platinum sponsor of the Connecticut Innovation Summit, a day-long program for executives, entrepreneurs, rising technology leaders, and investors to come together to share ideas and promote innovation. The program includes mentor meetings, a funding fair, a sales pitch competition, a poster expo, and an awards ceremony.

Presenters: Steven Coyle, Anne Maxwell, Ph.D., David Rodrigues, Ph.D.

Anne Maxwell, Ph.D. presented "Kyocera Wireless Corp. v. ITC" at the 25th Annual JPPCLE Conference.